Theorem eyes an Indian expansion with latest partnership

CRO Theorem Clinical Research has inked a deal with India's Excel Life Sciences to broaden its footprint in the country, expanding its access to clinical trial sites and bolstering its patient-recruitment capabilities.

Through the deal, Theorem will get access to Excel's network of more than 1,000 hospitals and research centers across 25 Indian cities, the company said, allowing it to offer clinical trial sponsors a wealth of options in the country.

Excel specializes in site management, handling the particulars of enrollment and retention to allow investigators to focus on patient care, and tapping the company's expertise will help speed up the process and better ensure success, Theorem Senior Vice President Marc Hoffman said.

"Collaborating together, we can offer sponsor companies access to a wealth of high-quality research centers in India, a well-established research team with a strong understanding of ICH-GCP and, most importantly, the local knowledge for successful conduct of studies in country," Hoffman said in a statement.

The agreement follows a slew of partnerships for the expansion-minded Theorem. Over the past year, the Pennsylvania CRO has signed deals with Decision Driver Analytics to expand its post-market efforts, teamed up with Charles River Laboratories ($CRL) on preclinical research and reached out to Emergo to better capitalize on med tech.

- read the announcement

Suggested Articles

The platform uses wearables to continuously collect clinical data from study participants and applies machine learning to analyze the data.

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.